• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙慢性阻塞性肺疾病史评估:多维慢性阻塞性肺疾病评估。研究方法和组织。

Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization.

机构信息

Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, España.

出版信息

Arch Bronconeumol. 2012 Dec;48(12):453-9. doi: 10.1016/j.arbres.2012.05.006. Epub 2012 Jul 4.

DOI:10.1016/j.arbres.2012.05.006
PMID:22766419
Abstract

INTRODUCTION

This present paper describes the method and the organization of the study known as the COPD History Assessment In SpaiN (CHAIN), whose main objective is to evaluate the long-term natural history of a chronic obstructive pulmonary disease (COPD) patient cohort from a multidimensional standpoint and to identify clinical phenotypes, in comparison with another non-COPD control cohort.

PATIENTS AND METHODS

CHAIN is a multicenter, observational study of prospective cohorts carried out at 36 Spanish hospitals. Both cohorts will be followed-up during a 5-year study period with complete office visits every 12 months and telephone interviews every 6 months in order to evaluate exacerbations and the vital state of the subjects. The recruitment period for cases was between 15 January 2010 and 31 March 2012. At each annual visit, information will be collected on: (i) clinical aspects (socio-economic situation, anthropometric data, comorbidities, smoking, respiratory symptoms, exacerbations, quality of life, anxiety-depression scale, daily life activities, treatments); (ii) respiratory function (spirometry, blood gases, hyperinflation, diffusion, respiratory pressures); (iii) BODE index (main study variable); (iv) peripheral muscle function, and (v) blood work-up (including IgE and cardiovascular risk factors). In addition, a serum bank will be created for the future determination of biomarkers. The data of the patients are anonymized in a database with a hierarchical access control in order to guarantee secure information access. The CHAIN study will provide information about the progression of COPD and it will establish a network of researchers for future projects related with COPD.

摘要

简介

本研究描述了 COPD 西班牙研究(CHAIN)的方法和组织,其主要目的是从多维角度评估慢性阻塞性肺疾病(COPD)患者队列的长期自然史,并与另一个非 COPD 对照组进行比较,确定临床表型。

患者和方法

CHAIN 是一项在 36 家西班牙医院进行的多中心、前瞻性队列观察研究。两个队列将在为期 5 年的研究期间进行随访,每 12 个月进行一次完整的门诊随访,每 6 个月进行一次电话随访,以评估加重情况和受试者的生命状态。病例的招募期为 2010 年 1 月 15 日至 2012 年 3 月 31 日。在每年的就诊时,将收集以下信息:(i)临床方面(社会经济状况、人体测量数据、合并症、吸烟、呼吸症状、加重情况、生活质量、焦虑抑郁量表、日常生活活动、治疗);(ii)呼吸功能(肺量计、血气、过度充气、扩散、呼吸压力);(iii)BODE 指数(主要研究变量);(iv)外周肌肉功能;以及(v)血液检查(包括 IgE 和心血管危险因素)。此外,还将建立一个血清库,用于未来确定生物标志物。患者的数据在一个具有分层访问控制的数据库中进行匿名化,以确保安全的信息访问。CHAIN 研究将提供 COPD 进展的信息,并将建立一个与 COPD 相关的未来项目的研究人员网络。

相似文献

1
Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization.西班牙慢性阻塞性肺疾病史评估:多维慢性阻塞性肺疾病评估。研究方法和组织。
Arch Bronconeumol. 2012 Dec;48(12):453-9. doi: 10.1016/j.arbres.2012.05.006. Epub 2012 Jul 4.
2
The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.慢性阻塞性肺疾病的进展是异质的:BODE 队列的经验。
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1015-21. doi: 10.1164/rccm.201105-0831OC.
3
Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.合并症作为慢性阻塞性肺疾病患者多维预后评估的一个要素。
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:297-301.
4
Improving in-office discussion of chronic obstructive pulmonary disease: results and recommendations from an in-office linguistic study in chronic obstructive pulmonary disease.改善慢性阻塞性肺疾病的门诊讨论:一项慢性阻塞性肺疾病门诊语言研究的结果与建议
Am J Med. 2007 Aug;120(8 Suppl 1):S28-32. doi: 10.1016/j.amjmed.2007.04.010.
5
[Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods].[PAC-COPD研究中慢性阻塞性肺疾病的表型特征及病程:设计与方法]
Arch Bronconeumol. 2009 Jan;45(1):4-11. doi: 10.1016/j.arbres.2008.03.001. Epub 2009 Jan 3.
6
[Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET].[慢性阻塞性肺疾病(COPD)患者的全身表现及合并症及其对疾病临床状态和病程的影响——队列研究COSYCONET综述]
Dtsch Med Wochenschr. 2010 Mar;135(10):446-9. doi: 10.1055/s-0030-1249185. Epub 2010 Mar 2.
7
The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.瑞典北部阻塞性肺病慢性阻塞性肺疾病研究:设计、第一年参与情况及死亡率
Clin Respir J. 2008 Oct;2 Suppl 1:64-71. doi: 10.1111/j.1752-699X.2008.00086.x.
8
Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease.与慢性阻塞性肺疾病恶化相关的住院因素。
Arch Bronconeumol. 2012 Mar;48(3):70-6. doi: 10.1016/j.arbres.2011.10.009. Epub 2011 Dec 21.
9
Peripheral arterial disease in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的外周动脉疾病
Int Angiol. 2012 Oct;31(5):444-53.
10
[COPD: what is there beyond BODE index?].[慢性阻塞性肺疾病:除了BODE指数还有什么?]
Arch Bronconeumol. 2009;45 Suppl 5:35-9. doi: 10.1016/S0300-2896(09)72953-9.

引用本文的文献

1
The Natural History of Severe Chronic Obstructive Pulmonary Disease: The SPOCCAT Study Protocol.重度慢性阻塞性肺疾病的自然史:SPOCCAT研究方案。
Open Respir Arch. 2024 Apr 4;6(2):100321. doi: 10.1016/j.opresp.2024.100321. eCollection 2024 Apr-Jun.
2
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.全球阻塞性肺病倡议 I COPD 患者低一氧化碳弥散量的临床和预后影响。
Chest. 2021 Sep;160(3):872-878. doi: 10.1016/j.chest.2021.04.033. Epub 2021 Apr 24.
3
Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in Smokers.
吸烟者的夜间低氧血症与CT测定的肺动脉增大
J Clin Med. 2021 Jan 30;10(3):489. doi: 10.3390/jcm10030489.
4
COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.COPD 临床控制:CHAIN 队列的预测因素和长期随访。
Respir Res. 2021 Feb 4;22(1):36. doi: 10.1186/s12931-021-01633-y.
5
Defining severe obstructive lung disease in the biologic era: an endotype-based approach.定义生物时代的严重阻塞性肺病:基于表型的方法。
Eur Respir J. 2019 Nov 21;54(5). doi: 10.1183/13993003.00108-2019. Print 2019 Nov.
6
Longitudinal change of FEV and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD.第一秒用力呼气容积(FEV)和吸气容量的纵向变化:对慢性阻塞性肺疾病(COPD)患者的临床意义及与急性加重风险的相关性
Int J Chron Obstruct Pulmon Dis. 2019 Feb 4;14:361-369. doi: 10.2147/COPD.S189384. eCollection 2019.
7
Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.基于表型的慢性阻塞性肺疾病管理方法的分布与结局:CHAIN队列研究结果
PLoS One. 2016 Sep 29;11(9):e0160770. doi: 10.1371/journal.pone.0160770. eCollection 2016.
8
New GOLD classification: longitudinal data on group assignment.新 GOLD 分类:分组的纵向数据。
Respir Res. 2014 Jan 13;15(1):3. doi: 10.1186/1465-9921-15-3.